A newly-formed investment management business, Carrara Investment Management manages Australian equities via the company Concentrated Leaders Fund, with plans to build a broader business in global equities, trading and credit over the coming years.
A publicly-listed biopharmaceutical company with three clinically advanced products in development, XORTX Therapeutics’ focus is on developing drugs for kidney disease treatment, an area where there is a large unmet medical need for therapeutics.